-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Head to Head Review: Smart for Life (NASDAQ:SMFL) Versus Jinhua Marine Biological (OTCMKTS:JNMB)
Head to Head Review: Smart for Life (NASDAQ:SMFL) Versus Jinhua Marine Biological (OTCMKTS:JNMB)
Smart for Life (NASDAQ:SMFL – Get Rating) and Jinhua Marine Biological (OTCMKTS:JNMB – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.
Earnings and Valuation
This table compares Smart for Life and Jinhua Marine Biological's top-line revenue, earnings per share and valuation.
Get Smart for Life alerts:| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smart for Life | $9.02 million | 0.92 | -$7.77 million | N/A | N/A |
| Jinhua Marine Biological | N/A | N/A | N/A | N/A | N/A |
Jinhua Marine Biological has lower revenue, but higher earnings than Smart for Life.
Analyst Recommendations
This is a breakdown of recent recommendations for Smart for Life and Jinhua Marine Biological, as provided by MarketBeat.com.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
| Jinhua Marine Biological | 0 | 0 | 0 | 0 | N/A |
Smart for Life currently has a consensus price target of $8.00, indicating a potential upside of 3,375.24%. Given Smart for Life's higher possible upside, equities analysts plainly believe Smart for Life is more favorable than Jinhua Marine Biological.
Institutional and Insider Ownership
0.4% of Smart for Life shares are held by institutional investors. 45.1% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Profitability
This table compares Smart for Life and Jinhua Marine Biological's net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Smart for Life | -139.56% | -1,377.59% | -94.78% |
| Jinhua Marine Biological | N/A | N/A | N/A |
Summary
Smart for Life beats Jinhua Marine Biological on 5 of the 8 factors compared between the two stocks.
About Smart for Life
(Get Rating)
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
About Jinhua Marine Biological
(Get Rating)
Jinhua Marine Biological (USA), Inc. develops allopelagic materials, biological medicines, pesticides, environmental protection products, and products for the home. It offers health products, including Xiduoan, which is used for strengthening and adjusting the immune system. The company also introduces advanced wastewater treatment technology, as well as develops environmental protection projects, including industry/urban wastewater treatment. This business was pursued in three areas: the development, manufacture, distribution and sale of ERGOS Systems directly by the Company; consulting services, and the delivery of marketing and other services to ERGOS network providers.
Receive News & Ratings for Smart for Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smart for Life and related companies with MarketBeat.com's FREE daily email newsletter.
Smart for Life (NASDAQ:SMFL – Get Rating) and Jinhua Marine Biological (OTCMKTS:JNMB – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, risk, earnings and institutional ownership.
Smart for Life（纳斯达克股票代码：SMFL — 获取评级）和金华海洋生物（OTCMKTS: JNMB — 获取评级）都是医疗公司，但哪只股票更好？我们将根据两家公司的股息、估值、分析师建议、盈利能力、风险、收益和机构所有权对两家公司进行比较。
Earnings and Valuation
收益和估值
This table compares Smart for Life and Jinhua Marine Biological's top-line revenue, earnings per share and valuation.
该表比较了Smart for Life和金华海洋生物的最高收入、每股收益和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Smart for Life | $9.02 million | 0.92 | -$7.77 million | N/A | N/A |
| Jinhua Marine Biological | N/A | N/A | N/A | N/A | N/A |
| 总收入 | 价格/销售比率 | 净收入 | 每股收益 | 市盈率 | |
| 为生活而聪明 | 902 万美元 | 0.92 | -777 万美元 | 不适用 | 不适用 |
| 金华海洋生物 | 不适用 | 不适用 | 不适用 | 不适用 | 不适用 |
Jinhua Marine Biological has lower revenue, but higher earnings than Smart for Life.
金华海洋生物的收入较低，但收入却高于Smart for Life。
Analyst Recommendations
分析师建议
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Smart for Life | 0 | 0 | 1 | 0 | 3.00 |
| Jinhua Marine Biological | 0 | 0 | 0 | 0 | N/A |
| 卖出评级 | 保持收视率 | 买入评级 | 强劲的买入评级 | 评分分数 | |
| 为生活而聪明 | 0 | 0 | 1 | 0 | 3.00 |
| 金华海洋生物 | 0 | 0 | 0 | 0 | 不适用 |
Smart for Life currently has a consensus price target of $8.00, indicating a potential upside of 3,375.24%. Given Smart for Life's higher possible upside, equities analysts plainly believe Smart for Life is more favorable than Jinhua Marine Biological.
Smart for Life目前的共识目标价为8.00美元，表明潜在的上涨空间为3,375.24％。鉴于Smart for Life可能有更高的上行空间，股票分析师明确认为，Smart for Life比金华海洋生物更有利。
Institutional and Insider Ownership
机构所有权和内部所有权
0.4% of Smart for Life shares are held by institutional investors. 45.1% of Smart for Life shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
Smart for Life的股票中有0.4％由机构投资者持有。45.1％的Smart for Life股票由内部人士持有。强大的机构所有权表明，对冲基金、大型基金经理和捐赠基金认为，从长远来看，股票的表现将超过市场。
Profitability
盈利能力
This table compares Smart for Life and Jinhua Marine Biological's net margins, return on equity and return on assets.
该表比较了Smart for Life和金华海洋生物的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Smart for Life | -139.56% | -1,377.59% | -94.78% |
| Jinhua Marine Biological | N/A | N/A | N/A |
| 净利润 | 股本回报率 | 资产回报率 | |
| 为生活而聪明 | -139.56% | -1,377.59% | -94.78% |
| 金华海洋生物 | 不适用 | 不适用 | 不适用 |
Summary
摘要
Smart for Life beats Jinhua Marine Biological on 5 of the 8 factors compared between the two stocks.
两只股票的比较中，Smart for Life在8个因素中的5个方面击败了金华海洋生物。
About Smart for Life
关于 “智慧生活”
(Get Rating)
（获取评分）
Smart for Life, Inc. acquires, develops, manufactures, operates, markets, and sells nutraceutical and related products in the United States and internationally. It offers natural health and wellness meal replacement products, including nutrition bars, cookies, soups and shakes, vitamins, and supplements; dietary supplements; nutritional supplements for athletes and active lifestyle consumers comprising powders, tablets, and soft gels; and various nutritional supplements. It sells its products through online market platforms. The company was formerly known as Bonne Santé Group, Inc. and changed its name to Smart for Life, Inc. in August 2021. Smart for Life, Inc. was founded in 2002 and is based in Miami, Florida.
Smart for Life, Inc. 在美国和国际上收购、开发、制造、运营、营销和销售营养品及相关产品。它提供天然健康和保健代餐产品，包括营养棒、饼干、汤和奶昔、维生素和补品；膳食补充剂；为运动员和活跃生活方式消费者提供的营养补充剂，包括粉末、片剂和软凝胶；以及各种营养补充剂。它通过在线市场平台销售其产品。该公司前身为 Bonne Sante Group, Inc.，并于 2021 年 8 月更名为 Smart for Life, Inc.Smart for Life, Inc. 成立于 2002 年，总部位于佛罗里达州迈阿密。
About Jinhua Marine Biological
关于金华海洋生物
(Get Rating)
（获取评分）
Jinhua Marine Biological (USA), Inc. develops allopelagic materials, biological medicines, pesticides, environmental protection products, and products for the home. It offers health products, including Xiduoan, which is used for strengthening and adjusting the immune system. The company also introduces advanced wastewater treatment technology, as well as develops environmental protection projects, including industry/urban wastewater treatment. This business was pursued in three areas: the development, manufacture, distribution and sale of ERGOS Systems directly by the Company; consulting services, and the delivery of marketing and other services to ERGOS network providers.
金华海洋生物（美国）公司开发同种异体物质、生物药物、杀虫剂、环保产品和家庭用品。它提供健康产品，包括用于增强和调整免疫系统的喜多安。该公司还引进先进的废水处理技术，并开发环境保护项目，包括工业/城市废水处理。该业务分三个领域开展：公司直接开发、制造、分销和销售ERGOS系统；咨询服务，以及向ERGOS网络提供商提供营销和其他服务。
Receive News & Ratings for Smart for Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smart for Life and related companies with MarketBeat.com's FREE daily email newsletter.
每天接收 Smart for Life 的新闻和评级 -在下面输入您的电子邮件地址，即可通过Marketbeat.com的免费每日电子邮件时事通讯接收Smart for Life及相关公司的最新新闻和分析师评级的简明每日摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧